tm logo
FRONTIER MEDICINES
REGISTERED

on 08 Nov 2024

Last Applicant/ Owned by

FRONTIER MEDICINES CORPORATION

151 Oyster Point Blvd., 2nd FloorSouth San Francisco, CA 94080

US

Serial Number

2198561 filed on 18th Jul 2022

Registration Number

TMA1268448 registered on 08th Nov 2024

Registration expiry Date

08th Nov 2034

Correspondent Address

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

FRONTIER MEDICINES

Trademark usage description

small molecule pharmaceuticals for the treatment of cancer, heart disease, blood pressure, alzheimer's disease, arthritis, diabetes, cancer, obesity, Read More

Classification Information


Class [005]
Small molecule pharmaceuticals for the treatment of cancer, heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, cancer, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases namely, spinal muscular atrophy diseases, spinal ataxia diseases, Huntington's disease, muscular dystrophy, spina bifida, Parkinson's disease, Alzheimer's disease, stroke, spinal cord injuries, brain injuries, seizure disorders, epilepsy, brain tumors, meningitis, cerebral palsy, multiple sclerosis, myasthenia gravis, allergies and asthma, hepatic disease, pulmonary disease, renal disease, and infectious diseases in humans.


Classification kind code

11

Class [042]
Pharmaceutical research services; pharmaceutical products development; research and development of pharmaceuticals for the treatment of cancer.


Classification kind code

11

Mark Details


Serial Number

2198561

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 08th Nov 2024
Registration Pending
Submitted for opposition 42
on 21st Aug 2024
Advertised
Submitted for opposition 26
on 23rd Jul 2024
Approved
Submitted for opposition 27
on 23rd Jul 2024
Approval Notice Sent
Submitted for opposition 22
on 25th May 2023
Search Recorded
Submitted for opposition 20
on 25th May 2023
Examiner's First Report
Submitted for opposition 287
on 22nd Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 18th Jul 2022
Filed
Submitted for opposition 1
on 18th Jul 2022
Created
Submitted for opposition 31
on 18th Jul 2022
Formalized